Darbepoetin Administration to Preterm Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Infant, Newborn
Interventions
DRUG

Darbepoetin Alfa Injection

darbepoetin alfa injection 10 mics/kg once a week SC for 10 weeks or until 35 completed weeks

DRUG

erythropoietin alfa injection

Epo 400 units/kg 3 x weekly SC for 10 weeks or until 35 completed weeks gestation

DRUG

sham injection

sham injection other names: not applicable

Trial Locations (3)

80218

University of Colorado, Denver

84103

LDS Hospital, Salt Lake City

84403

McKay-Dee Hospital, Ogden

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Intermountain Health Care, Inc.

OTHER

lead

University of New Mexico

OTHER

NCT00334737 - Darbepoetin Administration to Preterm Infants | Biotech Hunter | Biotech Hunter